Free press releases distribution network?

Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Opportunities and Future of Lab-on-A-Chip Technology in Diagnostics - A Market with High Potential as Diagnostics become Centre Stage and Instrumental for the Move to Preventive Medicine
Opportunities and Future of Lab-on-A-Chip Technology in Diagnostics

 

PRZOOM - /newswire/ - Kuala Lumpur, Malaysia, 2009/03/26 - A Market with High Potential as Diagnostics become Centre Stage and Instrumental for the Move to Preventive Medicine.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

While the in-vitro diagnostic (IVD) market is still very much focused upon among the Big Three: US, Europe and Japan, where they together constitute 90 percent of the 2007 global revenue, emerging countries such as India, Brazil and China are expected to become important stakeholders within the next few years.

According to Frost & Sullivan's latest white paper on In Vitro Diagnostics market, "The global IVD market has shown a consistent growth of 6.72 percent annually, a trend that is expected to continue until 2012. Point-of-Care (PoC), the largest segment, is estimated to grow into an $18 billion USD market by 2012 and Molecular Diagnostics is fast becoming an important component as it registers a 15.4 percent growth annually."

At present, the majority of this market is monopolized by large companies but that will be expected to change as smaller companies with more innovative technologies enter the arena. The lab-on-a-chip (LOAC) technology is one of them. The successful assimilation of LOAC technology would revolutionize the field of clinical diagnostics. While the standard infrastructure clearly defines the limitations between the healthcare practitioner and the laboratory personnel, LOAC technology may soon blur these lines.

LOACs are designed to increase the robustness of analysis and speed of delivery, allowing a simplified process of diagnosis and screening of diseases. LOACs, which have the capability of combining multiple technologies on a single platform, are at present largely limited to the laboratory space. However with the potential incorporation of process simplification as well as the other factors mentioned above, they are poised to penetrate the diagnostics market aimed at the full spectrum of opportunities including PoC.

LOAC may hold the key to the future of the IVD market. The global effort on various genomic projects, including human and other organisms, continue to provide valuable genetic information and knowledge, thus advancing biotechnology product development, including new drug discoveries and IVD. The latter is more poised to benefit from these government funded genome projects as it does not need complicated functional genomics on these newly identified sequences as required by new drug discoveries.

There is currently a need for an affordable, sensitive and rapid test, which is easy to perform and can be used in laboratories with very little experience or no experience in molecular biological methods – LOAC technology is positioned to address this gap. LOAC is perceived to provide faster result and has always been obtaining reliable and repeatable result. Other factors that will sustain growth in the LOAC technology market are rising lifestyle diseases, aging population, rising healthcare needs and consumer purchasing power.

Over and above the advantages listed here, the LOAC technology for diagnostic testing aims to bring together the different steps in a laboratory setting onto one chip. Because of the simplified process, even physicians can easily perform the tests at PoC, negating the necessity for sending samples to high-tech laboratories and waiting for days for the results. LOAC technology provides higher data quality, better controllable process parameters.

Senior Consultant, Purna Dhara further elaborates, "The growth of IVD today stems largely from the rise of chronic and infectious diseases which will continue to play a very important role with the increase in the aging population. HIV continues to be an important indicator for growth of IVD as over 33 million patients continue to live with this virus. Other growth drivers in the IVD industry are the increasing health care spending in emerging markets, extending accessibility to more healthcare services and products and developing awareness of health and disease prevention."

Frost & Sullivan's latest white paper on In Vitro Diagnostics is entitled Opportunities and Future of Lab-on-A-Chip Technology in Diagnostics. This report is available at frost.com. If you are interested in to read the white paper, then kindly send an email to either contacts below. A link will be sent to you.

About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 31 offices on six continents.

Jasminder Kaur
Corporate Communications – Healthcare, Asia Pacific
DID: +65 6890 0937
E: jkaur[.]frost.com

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Frost & Sullivan

 
 

Availability: All Metropolitan Area

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Opportunities and Future of Lab-on-A-Chip Technology in Diagnostics

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Frost & Sullivan |
Contact: Emmie Kaur 
+603 6204 5913 emmie.kaur[.]frost.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Frost & Sullivan / Company Profile


Read Medical Services/Equipment Most Recent Related Press Releases:

Sparta Systems Broadens Partnership with TrackWise Implementation Specialist Equality Systems
Thales Launches the Pixium Portable 3543 DR Wifi Enabled Flat Panel Detector
GE Healthcare Showcases Industry-first Technologies and Digital Solutions, Focused on Improving Outcomes, At RSNA 2016
Agfa and LCsys Team Up to Launch ABSOLUT-ID, Their Turnkey Integrated Solution for the Production of High Security ID Cards
ZOLL Technology for Improving CPR Quality to be Showcased at American Heart Association Annual Conference
AccuVein to Exhibit Leading Vein Visualization Technology at American Society for Dermatologic Surgery Annual Meeting
US Biomedical Textiles Transform Implant Device Technology by Aligning to Changes in Patient Preference Finds Frost & Sullivan
Frost & Sullivan Commends Influence Health for Constantly Evolving its Patient Engagement Products to Accelerate Market Transformation
Frost & Sullivan Awards Carestream Top Honors for OnSight 3D Extremity System
Sparta Systems Launches the Next-Generation Cloud Solution Stratas QMS

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  BizJobs.com

Visit  La Bella Bakery Artisan Bakery Arizona

Visit  Triggr & Bloom







 
  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today